LENSAR Inc (LNSR) Stock Analysis

What LENSAR Inc does

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Key metrics

ETFs linked to LNSR

Broad-market and Healthcare sector ETFs an investor holding LENSAR Inc is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how LNSR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for LENSAR Inc?

LENSAR Inc trades under the ticker LNSR on NASDAQ.

Which exchange is LNSR listed on?

LNSR is listed on NASDAQ.

What sector does LENSAR Inc operate in?

LENSAR Inc is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze LNSR in a portfolio?

PortView shows LNSR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.